<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03414099</url>
  </required_header>
  <id_info>
    <org_study_id>USM/JEPeM/17050243</org_study_id>
    <nct_id>NCT03414099</nct_id>
  </id_info>
  <brief_title>Ketum and Pain Tolerence</brief_title>
  <official_title>Ketum and Pain Tolerence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Science Malaysia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Science Malaysia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aim is to evaluate potential analgesic properties of ketum using the cold pressor
      task.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants in the proposed study will be males who report consuming ketum more than once a
      day, daily for the past 12 months. The study is a placebo-controlled, double-blind
      within-subject repeated mesaures design. Participants will ingest a sequence of ketum and
      placebo drinks prepared by pharmacologists at USM Centre for Drug Research and their pain
      tolerance will be measured by the cold pressor task after ingesting ketum or placebo.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 23, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Within-subject, repeated measures</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Ketum and placebo drinks will be matched for taste and appearence. Each study participant will receive a sequence of ketum and placebo drinks in random order.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain tolerance</measure>
    <time_frame>3 hours</time_frame>
    <description>The duration (seconds) participants can keep their hands immersed in the water bath</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Ketum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each participant will consume a sequence of active ketum or placebo drinks (4 drinks total). Pain tolerance will be measured using the cold pressor task after consuming each drink.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Each participant will consume a sequence of active ketum or placebo drinks (4 drinks total). Pain tolerance will be measured using the cold pressor task after consuming each drink.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketum</intervention_name>
    <description>Ketum (Mitragyna speciosa) is an indigenous plant of Southeast Asia reported to have medicinal value in traditional culture</description>
    <arm_group_label>Ketum</arm_group_label>
    <other_name>Kratom</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo drink matched for taste and appereance</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: males who report drinking ketum juice more than once a day, daily for
        the past 12 months.

        Exclusion Criteria: (1) tested positive for illicit drug use including morphine, cannabis,
        methamphetamine, amphetamine, methadone, benzodiazepine and ketamine; (2) have current or
        previous history of psychological or neurological problems (self-report); (3) have current
        or previous alcohol use history (self-report); (4) HIV infections; (5) history of chronic
        liver disease (e.g. cirrhosis, hepatitis A, B, C, etc.) 6) non-alcoholic fatty liver
        disease; (7) history of coronary heart disease and diabetes; (8) existing chronic pain
        condition and (9) history of psychiatric disorders.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vicknasingam Kasinather, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohd Bazlan Hafidz Mukrim, BSc</last_name>
    <phone>609-7672354</phone>
    <phone_ext>2362</phone_ext>
    <email>bazlan@usm.my</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre for Drug Research, Univerisiti Sains Malaysia</name>
      <address>
        <city>Gelugor</city>
        <state>Penang</state>
        <zip>11800</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicknasingam Kasinather, PhD</last_name>
      <phone>604653272</phone>
      <email>vickna@usm.my</email>
    </contact>
    <investigator>
      <last_name>Vicknasingam Kasinather, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marek C Chawarski, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2018</study_first_submitted>
  <study_first_submitted_qc>January 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2018</study_first_posted>
  <last_update_submitted>January 30, 2018</last_update_submitted>
  <last_update_submitted_qc>January 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Science Malaysia</investigator_affiliation>
    <investigator_full_name>Vicknasingam B Kasinather</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Kratom</keyword>
  <keyword>Ketum</keyword>
  <keyword>mitragynine</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

